Redefining Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis Failures

被引：49
|
作者：
Marcus, Julia L. [1 ,2 ]
Hurley, Leo B. [3 ]
Dong Phuong Nguyen [4 ]
Silverberg, Michael J. [3 ]
Volk, Jonathan E. [4 ]
机构：
[1] Harvard Med Sch, Boston, MA USA
[2] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[3] Kaiser Permanente, Div Res, Oakland, CA USA
[4] Kaiser Permanente San Francisco, Med Ctr, San Francisco, CA USA
来源：
CLINICAL INFECTIOUS DISEASES | 2017年 / 65卷 / 10期
关键词：
D O I：
10.1093/cid/cix593
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1768 / 1769
页数：2
相关论文
共 50 条
  • [21] Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018
    Harris, Norma S.
    Johnson, Anna Satcher
    Huang, Ya-Lin A.
    Kern, Dayle
    Fulton, Paul
    Smith, Dawn K.
    Valleroy, Linda A.
    Hall, H. Irene
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (48): : 1117 - 1123
  • [22] Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations
    Cohen, Myron S.
    Landovitz, Raphael J.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01): : 1 - 3
  • [23] Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis
    Cottrell, Mackenzie L.
    Prince, Heather M. A.
    Schauer, Amanda P.
    Sykes, Craig
    Maffuid, Kaitlyn
    Poliseno, Amanda
    Chun, Tae-Wook
    Huiting, Erin
    Stanczyk, Frank Z.
    Peery, Anne F.
    Dellon, Evan S.
    Adams, Jessica L.
    Gay, Cindy
    Kashuba, Angela D. M.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (12) : 2201 - 2204
  • [24] Factors Influencing Willingness to Use Human Immunodeficiency Virus Preexposure Prophylaxis Among Transgender Women in India
    Chakrapani, Venkatesan
    Shaikh, Simran
    Arumugam, Visvanathan
    Chawla, Umesh
    Mehta, Sonal
    TRANSGENDER HEALTH, 2021, 6 (02) : 64 - 73
  • [25] Abandonment of Human Immunodeficiency Virus Preexposure Prophylaxis Prescriptions at Retail Pharmacies-United States, 2019
    Huang, Ya-Lin A.
    Zhu, Weiming
    Carnes, Neal
    Hoover, Karen W.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (03) : 512 - 514
  • [26] Integrating Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Into Women's Health Care in the United States
    Seidman, Dominika
    Weber, Shannon
    OBSTETRICS AND GYNECOLOGY, 2016, 128 (01): : 37 - 43
  • [27] Preexposure Prophylaxis for HIV Prevention
    Karim, Salim S. Abdool
    Gray, Glenda E.
    Martinson, Neil
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05): : 462 - 465
  • [28] Investigations of possible failures of postexposure prophylaxis following occupational exposures to human immunodeficiency virus
    Jochimsen, EM
    Luo, CC
    Beltrami, JF
    Respess, RA
    Schable, CA
    Cardo, DM
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (19) : 2361 - 2363
  • [29] HIV antiretroviral preexposure prophylaxis
    Tjan, Richard
    UNIVERSA MEDICINA, 2013, 32 (02) : 69 - 70
  • [30] Providing HIV preexposure prophylaxis
    Trischuk, Taisa
    Little, Bradley
    LeBras, Marlys
    CANADIAN FAMILY PHYSICIAN, 2022, 68 (03) : 197 - 201
12345